Accéder au contenu
Merck

Cutaneous findings leading to a diagnosis of superior vena cava syndrome: A case report and review of the literature.

Dermatology online journal (2011-06-24)
Mondhipa Ratnarathorn, Errol Craig
RÉSUMÉ

Superior vena cava syndrome, which occurs in approximately 15,000 persons in the United States annually, consists of a collection of symptoms and signs resulting from the obstruction of the superior vena cava (SVC). An early and prominent symptom of this condition is a constellation of superficial, dilated, vertically oriented and tortuous cutaneous venules or veins above the ribcage margins, often presenting as a blanchable violaceous eruption. Herein, we report a case of superior vena cava syndrome diagnosed in our dermatology clinic.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Dexaméthasone 21-phosphate disodium salt, ≥98%
Dexaméthasone 21-phosphate disodium salt, European Pharmacopoeia (EP) Reference Standard